Bridgewater Associates - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 362 filers reported holding NOVOCURE LTD in Q2 2021. The put-call ratio across all filers is 0.83 and the average weighting 0.2%.

Quarter-by-quarter ownership
Bridgewater Associates ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2023$438,117
-90.8%
27,128
-76.5%
0.00%
-90.0%
Q2 2023$4,781,879
-37.8%
115,226
-9.8%
0.03%
-36.2%
Q1 2023$7,682,524
-22.8%
127,744
-5.9%
0.05%
-13.0%
Q4 2022$9,956,749
-21.3%
135,743
-18.5%
0.05%
-15.6%
Q3 2022$12,651,000
+20.2%
166,502
+9.9%
0.06%
+42.2%
Q2 2022$10,527,000
-6.8%
151,470
+11.1%
0.04%
-2.2%
Q1 2022$11,291,000
+51.3%
136,280
+37.1%
0.05%
+7.0%
Q4 2021$7,463,000
-33.2%
99,401
+3.4%
0.04%
-29.5%
Q3 2021$11,165,000
-47.9%
96,106
-0.6%
0.06%
-55.8%
Q2 2021$21,437,00096,6420.14%
Other shareholders
NOVOCURE LTD shareholders Q2 2021
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 350,884$26,344,0008.01%
HARTLINE INVESTMENT CORP/ 318,109$23,884,0003.27%
Deep Track Capital, LP 550,000$41,294,0002.92%
MORGAN JESS S & CO INC 43,975$3,302,0002.03%
Taylor Frigon Capital Management LLC 46,376$3,482,0001.09%
Darsana Capital Partners LP 258,937$19,441,0000.90%
Private Harbour Investment Management & Counsel, LLC 13,562$1,018,0000.81%
Rhenman & Partners Asset Management AB 120,387$9,610,0000.64%
COURAGE CAPITAL MANAGEMENT LLC 10,000$751,0000.50%
Baillie Gifford 9,615,168$721,906,0000.40%
View complete list of NOVOCURE LTD shareholders